Placental stem cells: biological characteristics and approaches to clinical application

Home/2014, Vol. 2, No. 2/Placental stem cells: biological characteristics and approaches to clinical application

Cell and Organ Transplantology. 2014; 2(2):140-143.
DOI: 10.22494/COT.V2I2.31

Placental stem cells: biological characteristics and approaches to clinical application

Nasadyuk C. M.
Institute of Cell Therapy, Kyiv, Ukraine

Abstract
Literary data gives evidence that placenta is a rich source of stem cells that phenotypically correspond to human mesenchymal stem cells. The possibility of osteogenic and hepatogenic differentiation of placental mesenchymal stem cells was reported as well as their transformation into cardiomyocytes, adipocytes was shown. It was established that mesenchymal stem cells of placenta have the highest potential of osteogenic differentiation compared to the stem cells from other sources. The advantages of placental stem cells towards clinical application are ethical feasibility and non-invasive collection, high proliferative potential and immunomodulatory properties.

Full Text PDF

1. Nasadyuk CM. Cell Technology in Reproduction, Obstetrics and Gynecology. Cell and organ transplantology, 2013; 1(1):61-65.
https://doi.org/10.22494/cot.v1i1.46
2. Nasadyuk CM. Bіohіmіchna harakteristika ta pіdhodi do zastosuvannja ekstraktіv placenti v medichnіj prakticі [Biochemical characteristics and approaches to the use of placental extracts in medical practice]. З турботою про жінку – Caring for woman, 2013; 4(43): 54-56.
3. Nasadyuk CM. Pupovinna krov: mediko-bіologіchna harakteristika, zberіgannja, klіnіchne zastosuvannja Пуповинна кров: медико-біологічна характеристика, зберігання, клінічне застосування [Umbilical cord blood: medical and biological characterization, storage and clinical application]. Zhіnochij lіkar – Female doctor, 2009; 5: 53-56.
5. Overview of the Word Congress on Cord Blood and Innovative Approaches to The Treatment of Sickle-Cell Anemia in Monaco on 24-27 th October 2013. Cell and organ transplantology, 2014; 2(1):95-98.
6. Abumaree M H, Jumah A l. The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS). Int J Mol Sci. 2012; 13(7): 9298 – 9331.
PMid:22942767 PMCid:PMC3430298
7. Barcena A, Muench MO, Kapidzic M. Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation. Transfusion. 2011; 51(4): 94S-105S.
https://doi.org/10.1111/j.1537-2995.2011.03372.x
PMid:22074633 PMCid:PMC3266842
8. Chakraborty PD, De D, Bandyopadhyay S, et al. Human aqueous placental extract as a wound healer. J. Wound Care. 2009; 18:462-467.
https://doi.org/10.12968/jowc.2009.18.11.44987
PMid:19901875
9. Chen J, Shehadah A, Pal A, et al. Neuroprotective effect of human placenta-derived cell treatment of stroke in rats. Cell Transplant. 2013; 22(5): 871.
https://doi.org/10.3727/096368911X637380
PMid:22469567
10. Fan Z X, Lu Y, Deng L, et al. Placenta- versus bone-marrow-derived mesenchymal cells for the repair of segmental bone defects in a rabbit model. FEBS J. 2012; 279(13): 2455-2465.
https://doi.org/10.1111/j.1742-4658.2012.08625.x
PMid:22564891
11. Fazekasova H, Lechler R, Langford K, et al. Placenta derived MSCs are partially immunogenic and less immunomodulatory than bone marrow-derived MSCs J. Tissue Eng and Regen Med. 2011; 5(9): 684-694.
https://doi.org/10.1002/term.362
PMid:21953866
12. Fisher-Shoval Y, Barhum Y, Sadan O, et al. Transplantation of placenta-derived mesenchymal stem cells in the EAE mouse model of MS. J. Mol. Neurosci. 2012; 48(1): 176-184.
https://doi.org/10.1007/s12031-012-9805-6
PMid:22638856
13. Ilic N, Brooke G, Murray P, et al. Manufacture of clinical grade human placenta-derived multipotent mesenchymal stromal cells. Methods Mol. Biol. 2011; 698: 89-106.
https://doi.org/10.1007/978-1-60761-999-4_8
PMid:21431513
14. Lee JM, Jung J, Lee HJ, et al. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int. Immunopharmacol. 2012; 13(2): 219-224.
https://doi.org/10.1016/j.intimp.2012.03.024
PMid:22487126
15. Lee HJ, Jung J, Cho KJ, et al. Comparison of in vitro hepatogenic differentiation potential between various placenta-derived stem cells and other adult stem cells as an alternative source of functional hepatocytes. Differentiation. 2012; 84(3): 223-231.
https://doi.org/10.1016/j.diff.2012.05.007
PMid:22885322
16. Li F, Chen YZ, Miao ZN, et al. Human placenta-derived mesenchymal stem cells with silk fibroin biomaterial in the repair of articular cartilage defects. Cell Reprogram. 2012; 14(4): 334-341.
PMid:22816556
17. Li K, Li SZ, Zhang YL, et al. The effects of dan-shen root on cardiomyogenic differentiation of human placenta-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2011; 415(1):147-151.
https://doi.org/10.1016/j.bbrc.2011.10.035
PMid:22020077
18. Li J, Zhang H, Liu G. Research on anti-aging effect of mouse placenta cells transplantation. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010; 27(6):1312-6.
PMid:21374985
19. Lu GH, Yong WS, Xu ZM, et al. H. Human placental decidua basalis-derived mesenchymal stem cells differentiate into dopamine neuron-like cells with no response to long-term culture in vitro. Neuroreport. 2012; 30(23): 513-518.
https://doi.org/10.1097/WNR.0b013e328353fbb4
PMid:22525837
20. Malek A, Bersinger NA. Human placental stem cells: biomedical potential and clinical relevance. J. Stem Cells. 2011; 6(2): 75-92.
PMid:22997848
21. Oh EJ, Kim TK, Shin JH, et al. Biologic filler using human fibroblasts and placenta extracts. J. Craniofac. Surg. 2011; 22(5): 1557-1560.
https://doi.org/10.1097/SCS.0b013e31822e5c5e
PMid:21959386
22. Park S, Kim E, Koh SE. Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson’s disease model rats and alleviation of asymmetric rotational behavior. Brain Res. 2012; 1466: 158-166.
https://doi.org/10.1016/j.brainres.2012.05.032
PMid:22634376
23. Prather WR, Toren A, Meiron M, et al. The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia. Cytotherapy. 2009; 11(4): 427-34.
https://doi.org/10.1080/14653240902849762
PMid:19526389
24. Sun NZ, Ji H. In vitro differentiation of osteocytes and adipocytes from human placenta-derived cells. J. Int. Med. Res. 2012; 40(2): 761-767.
https://doi.org/10.1177/147323001204000242
PMid:22613441
25. Takeda Y, Uemura S, Iwama H, et al. Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arterogenesis andimproves survival after myocardial infarction. Circ. J. 2009; 73(9): 1674-1682.
https://doi.org/10.1253/circj.CJ-08-1067
PMid:19602778
26. Young PP, Schäfer R. Cell-based therapies for cardiac disease: a cellular therapist’s perspective Transfusion. 2014. http://www.ncbi.nlm.nih.gov/pubmed/?term=Cell-based+therapies+for+cardiac+disease%3A+a+cellular+therapist%27s+perspective.
27. Zhang D, Tong A, Zhou L, et al. Osteogenic differentiation of human placenta-derived mesenchymal stem cells (PMSCs) on electrospun nanofiber meshes. Cytotechnology. 2012; 64(6): 701-710.
https://doi.org/10.1007/s10616-012-9450-5
PMid:22526490 PMCid:PMC3488365
28. Zhong ZN, Zhu SF, Yuan AD, et al. Potential of placenta-derive mesenchymal stem cells for bone tissue engineering: preliminary study of osteoblastic differentiation and immunogenicity. Orthopedics. 2012; 35(9):779-788.
https://doi.org/10.3928/01477447-20120822-07
PMid:22955387
29. http://clinicaltrials.gov/

Nasadyuk CM. Рlacental stem cells: biological characteristics and approaches to clinical application. Cell and Organ Transplantology. 2014; 2(2):140-143. doi: 10.22494/COT.V2I2.31

 

Creative Commons License
Is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.